|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.56 USD | -4.79% |
|
+8.25% | +173.33% |
| 06-20 | Benchmark Adjusts Emergent Biosolutions Price Target to $8 From $5, Maintains Buy Rating | MT |
| 05-02 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
Emergent BioSolutions Inc. provided earnings guidance for the full year 2022. For the year, the company expects total revenues of $1,400 million to $1,500 million.
| 1st Jan change | Capi. | |
|---|---|---|
| +173.33% | 344M | |
| +54.61% | 811B | |
| +44.25% | 640B | |
| -6.33% | 353B | |
| +20.62% | 333B | |
| +10.44% | 302B | |
| +18.45% | 246B | |
| +2.09% | 225B | |
| +13.03% | 218B | |
| +8.61% | 168B |
EMERGENT BIOSOLUTIONS INC. 
